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The US research enterprise is under significant strain due to stagnant funding, an expanding workforce, and complex regulations that increase
costs and slow the pace of research. In response, a number of groups have analyzed the problems and offered recommendations for resolving
these issues. However, many of these recommendations lacked follow-up implementation, allowing the damage of stagnant funding and
outdated policies to persist. Here, we analyze nine reports published since the beginning of 2012 and consolidate over 250 suggestions into
eight consensus recommendations made by the majority of the reports.We then propose how to implement these consensus recommendations, and
we identify critical issues, such as improving workforce diversity and stakeholder interactions, on which the community has yet to achieve consensus.
biomedical workforce | research funding | research regulation | graduate training | postdoc training
The problems of the US biomedical research
enterprise have been well-documented. Stag-
nant federal funding since 2003 has reduced
grant success rates, eroded grant purchasing
power, and reduced employment (1–3). In
addition, young scientists often are not aware
of, or trained for, the breadth of careers avail-
able (4); burdensome regulations detract
from research productivity (5); and technol-
ogy transfer and intellectual property rights
remain divisive issues for academia, indus-
try, and government (6). These conditions
may cause a substantial fraction of the next
generation of scientists to conduct research
abroad or leave science altogether (7). We
must resolve these challenges and move the
US research enterprise onto a more sustain-
able path that balances workforce size with
available research funding while continuing
to cultivate world-class scientific talent and
produce breathtaking discoveries (8).
More than half a dozen groups have ana-
lyzed the problems confronting the enterprise
and made recommendations for improve-
ment. For a variety of reasons, however,
implementation of these recommendations
has been slow. For example, partisan politics
can impede the progress of necessary legisla-
tion, and relevant federal agencies lack either
the willingness or legal authority to make
needed changes. Furthermore, the lack of a
unified authority over university policies and
practices can lead to patchwork change with
variable results. Together, these attributes may
have led to a false sense that the community
has not yet achieved consensus around action-
able improvements, thereby impeding imple-
mentation of actions that would improve the
research enterprise.
To identify areas where action should be
taken immediately, we analyzed hundreds
of recommendations made by various groups,
and we identified eight recommendations that
were endorsed by a majority of leading rep-
resentatives of the scientific community
(Table1) (9–17).Weadvocate that the commu-
nity implement these consensus recommenda-
tions, offer straightforward implementation
plans, and identify additional critical issues that
must be resolved to continue moving the en-
terprise onto a more sustainable path.
Consensus Recommendations
We systematically searched for reports, meet-
ing summaries, and opinion pieces published
since 2012 that addressed sustainability prob-
lems confronting the research enterprise. Re-
ports published before 2012 were excluded
because recommendations made before then
were often obsolete, and multiple groups
representing different constituencies have
weighed in on these issues since then. We
also excluded reports that made recom-
mendations that affected only a subset of
the biomedical research enterprise.
The nine reports that fit these criteria
made a total of 267 recommendations, which
were consolidated to produce 54 “unique”
recommendations (Dataset S1) (9–17). Eight
of the 54 recommendations appeared in a
majority of the nine reports and were termed
“consensus” recommendations (SI Appendix,
Table 1). All of the reports emphasized the
importance of strengthening individual,
investigator-initiated research and rigorous
scientific training, and implementation of
the eight consensus recommendations should
proceed with these goals in mind.
Consensus Recommendation 1: The
Federal Government Should Make
Research Funding Predictable and
Sustainable
Five reports made this recommendation and
four specifically suggested that scientists and
scientific societies work with federal agencies
to develop a cross-agency, multiyear budget
plan (Table 1) (9, 10, 13, 17). Although the
specifics of a long-term budget plan did not
meet our consensus threshold, the most com-
mon recommendations were that funding
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requirements be projected for at least 5 y, be
revised annually, and include research in-
frastructure needs. We also suggest including
projections of the size and composition of the
research workforce in the budget plan. Al-
though obtaining such data may be difficult,
an accurate assessment of workforce needs is
critical for a sustainable research enterprise.
As suggested by some reports, creating a sys-
tem that tracks all researchers funded by fed-
eral grants may aid the collection of workforce
data (12, 14, 15). This long-term budget plan
will provide a roadmap for predictable and
sustainable research funding and improve the
transparency of agency spending.
Consensus Recommendation 2: The
Federal Government Should Increase
Overall Research Funding
In 2014, the United States invested approxi-
mately $465 billion, or 2.8% of its gross
domestic product (GDP), in research and
development (R&D) (18). Industry-funded
R&D was responsible for two-thirds of
this spending, federally funded R&D
accounted for one-quarter, and the re-
mainder came from academia, nonprofits, and
other funders (18). Five reports recommended
increasing research and development funding,
and three specifically advocated for increasing
investment to three percent or more of US
gross domestic product (Table 1) (10, 13, 17).
R&D investments are an important driver
of US GDP growth, but increasing R&D
spending to 3% of GDP did not reach our
threshold for consensus. However, this
funding level is a useful starting point for the
discussion. Additionally, two of the reports
specified that basic research should be the
primary beneficiary of funding increases (10,
13). We suggest using the long-term sci-
ence budget framework described above to
refine spending targets and research areas for
investment and to ensure that investments
are in line with workforce and infrastructure
needs. Increasing R&D spending to 3% of
GDP or beyond will also require a significant
investment increase by industry, nonprofits,
and other funders (18). One approach for
encouraging increased investment is tax
reform, particularly making the Research
and Experimentation Tax Credit permanent
(10, 13, 17, 19).
Consensus Recommendation 3: Federal
Agencies Should Streamline, Harmonize,
or Eliminate Burdensome Regulations
House Bill 1119 (H.R. 1119), the proposed
Research and Development Efficiency Act of
2015, would establish a federal interagency
working group to identify burdensome or
outdated regulations and recommend ways to
relieve this burden (20). Given the consensus
Table 1. Consensus recommendations and implementation plans
Recommendation Implementation* References†
1. The federal government should make
research funding predictable and
sustainable.
Federal agencies and scientific community: Develop long-term science budget with
reasonable and sustainable funding goals.
9, 10, 12, 17
2. The federal government should increase
overall research funding.
Federal agencies and scientific community: Determine appropriate research funding
level with 3% of GDP as a starting point.
9–11, 13, 17
Scientific community: Advocate for sustainable federal research funding as described in
long-term budget plan.
Federal government: Change policies to encourage R&D investment from
nongovernmental sectors.
3. Federal agencies should harmonize,
streamline, or eliminate burdensome
regulations.
Scientific community: Advocate for passage of H.R. 1119. 10, 11, 13, 15–17
Scientific community: Develop list of onerous regulations for review by federal
interagency panel.
4. Institutions and federal agencies should
increase compensation for postdoctoral
scholars.
NIH: Increase the postdoc pay scale, with $50,000 as a starting point for new
postdocs.
9, 10, 12, 14, 15
Institutions: Conform to NIH postdoc pay scale for all postdocs regardless of funding
source.
5. Institutions and federal agencies should
reduce graduate student and postdoc
training periods.
NIH: Limit graduate student support from all NIH grants to 5 y. Postdocs receive an
additional 5 y.
9, 10, 13–15, 17
Institutions: Pilot and implement methods to provide rigorous scientific training in a
shorter time.
6. Institutions and federal agencies should
train students and postdocs for the
breadth of careers available to them.
Institutions: Develop programs to expose all trainees to the variety of available careers. 9–15, 17
NIH: Disseminate innovative training approaches as learned through the BEST
program.
7. Institutions and federal agencies should
shift support of trainees toward training
grants and fellowships.
NIH: Increase training budget to accommodate higher postdoc pay while maintaining
the number of trainee slots.
9, 10, 12, 13, 15, 17
NIH: Amend peer-review processes to value quality training of all students at an
institution, regardless of funding source.
NIH: Determine target number of trainees to support by training grants and
fellowships, with 17% of all postdocs and 37% of all graduate students as starting
points.
8. Institutions and federal agencies should
increase the use of staff scientists.
Institutions: Create staff scientist positions with compensation commensurate with the
position.
9–12, 14, 15, 17
NIH: Modify peer-review criteria to encourage use of staff scientists.
*Implementation plans include recommendations specified in reports and the authors’ suggestions. See the text for a more detailed explanation of the implementation plans.
†The reports that support the recommendation.
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on reducing regulations, the benefit to sci-
entists, and the political will to address this
issue, the community should advocate for
passage of H.R. 1119 (Table 1). This bill
also directs the interagency working group
to work with the scientific community to
identify onerous regulations, and the
community should prepare to offer such
recommendations.
Consensus Recommendation 4:
Institutions and Federal Agencies
Should Increase Compensation for
Postdoctoral Scholars
Five reports recommended increasing com-
pensation for postdoctoral scholars (post-
docs) to reflect better their training and
critical contributions to the research enter-
prise, but only one proposed a specific pay
level for beginning postdocs—$50,000 (Table
1) (14). Although the community has not
yet reached consensus on how much sal-
aries should increase, $50,000 is a reasonable
starting point for discussion. In addition, we
recommend that institutions match the NIH
postdoc pay scale and that salary increases be
phased in at a rate that outpaces inflation.
Only one report suggested that graduate stu-
dent stipends be increased (11). Despite the
lack of consensus, graduate student stipend
levels should be assessed on a regular basis to
ensure fair compensation and sustainability.
Consensus Recommendation 5:
Institutions and Federal Agencies
Should Reduce Graduate Student and
Postdoc Training Periods
PhD training periods now average over 6.5 y,
and postdoc periods are expanding (21, 22).
These trends are contributing to the decades-
long increase in the average age of tenure-
track and tenured faculty members (15). Six
reports recommended reducing training pe-
riods, but the reports did not specify how this
goal should be accomplished or to what ex-
tent (Table 1). One possibility is to limit
graduate students to 5 y of total funding on
federal grants, including training grants, fel-
lowships, and research grants, and postdocs to
an additional 5 y. These limitations should be
phased in over multiple years, and exceptions
should be made for extraordinary circum-
stances, such as parental leave. Because
trainees funded by research grants are con-
sidered institutional employees, institutions
and the NIH would have to work together to
enact workable policies and ensure that non-
federal funds are not used to lengthen training
periods unnecessarily. As with consensus
recommendation 1, a system that tracks re-
searchers funded by federal grants may aid
implementation.
Consensus Recommendation 6:
Institutions and Federal Agencies Should
Train Students and Postdocs for the
Breadth of Careers Available to Them
Biomedical PhD graduates have been opting
for nonacademic careers in increasing num-
bers for three decades (11, 15). Academic in-
stitutions and federal funding agencies should
therefore increase opportunities for students
to explore careers other than academic re-
search, while maintaining rigorous scientific
training. Many institutions have begun to
implement such expanded training programs,
and the NIH’s Broadening Experiences in
Scientific Training (BEST) program recently
awardedgrants to support suchendeavors (23).
Institutions should model expanded training
programs on successful BEST programs. The
NIHalso now requires individual development
plans for each supported trainee, and institu-
tions should strongly encourage and support
their thoughtful use in career planning (24, 25).
Consensus Recommendation 7:
Institutions and Federal Agencies
Should Shift Support of Trainees Toward
Fellowships and Training Grants
Four of the six reports supporting consensus
recommendation 7 argued that training
will be strengthened by a greater decoupling
of training and research activity, and by
giving federal agencies more oversight of
training programs through peer review (Ta-
ble 1) (9, 10, 13, 15). In 2012, 9.6% of post-
docs and 32% of full-time graduate students
were supported by federal training grants and
fellowships (26, 27). Although the reports did
not come to consensus on how many trainees
should be funded by training grants and
fellowships, the NIH should begin to gradu-
ally increase the number of graduate students
and postdocs funded by these mechanisms.
We note that, in 1998 before the NIH budget
doubling, the percentages of postdocs and
graduate students funded by training grants
and fellowships were ∼17% and 37%,
respectively, and these levels are a useful
starting point for discussion (26, 27). These
discussions should also consider some short-
comings of current training mechanisms. For
example, only permanent residents are eligible
for this funding, the mechanisms do not fully
cover training costs, and efforts to control the
supply and demand of PhDs and postdocs are
controversial (see Conclusion).
Consensus Recommendation 8:
Institutions and Federal Agencies Should
Increase the Use of Staff Scientists
The seven reports supporting consensus
recommendation 8 argued that adding more
stable staff scientists will have several benefits,
including improved long-term laboratory
stability and increased productivity (Table 1).
Institutions should establish formal positions
with pay scales that are attractive enough to
make this career path desirable and viable,
not just a default step for senior postdocs. In
parallel, federal funding agencies should amend
peer-review policies to encourage grant appli-
cations that include staff scientists. The Na-
tional Cancer Institute has recently launched a
program to fund staff scientists, which will
serve as a useful test case (28).
Issues Requiring Further Consideration
Implementing the above consensus recom-
mendations will not solve all of the problems
in the research enterprise, and each of the
reports made many more recommendations
that did not reach our consensus threshold.
Moreover, several very important topics were
not adequately addressed by these reports,
some of which are highlighted here.
Workforce Diversity. Diverse groups often
solve problems more effectively than homo-
geneous groups, yet women and many racial
and ethnic groups are underrepresented in
the research enterprise (29, 30). However, only
one report in our analysis addressed this issue
in any depth (10). Diversity must be part of
any reform discussion because workforce
changes, including implementing consensus
recommendations 4 through 8, will inevitably
affect diversification efforts. Increasing mi-
nority participation in research must go be-
yond enhancing kindergarten-to-twelfth grade
(K–12) science, technology, engineering, and
mathematics (STEM) education programs for
underrepresented minority students (31, 32).
The scientific community must also move
quickly to identify and reform structural in-
equities such as unconscious bias in hiring
and peer review and institutional cultures that
select against women and underrepresented
minorities (33–36).
Stakeholder Interactions. The analyzed
reports focused primarily on academic sci-
ence, but the interactions among academia,
industry, and government also play key roles
in the research enterprise. Indirect cost re-
covery rates and allowable uses of these funds
require further discussions between govern-
ment and academia (37). The Bayh–Dole Act
of 1980 laid the foundation for the current
state of technology transfer and innovation
licensing (38). However, technology transfer
and intellectual property issues still impede
the seamless flow of ideas and materials (39).
The reproducibility of academic science as it
relates to drug development is also a point of
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contention between academia and industry
(40). Greater engagement among academia,
industry, and government is required to
address these concerns and other critical
interstakeholder issues. The National Academy
of Sciences’ Government-University-Industry
Research Roundtable provides a natural fo-
rum for these discussions, and stakeholders
should use this council and additional ave-
nues to improve stakeholder interactions.
Grant-Funding Mechanisms. Six of the
nine analyzed reports proposed new grant-
funding mechanisms but differed on the con-
stituencies they should target. Some target
groups included young scientists, senior sci-
entists, physician scientists, and those in need
of bridge funding (11, 12, 15, 17). Mechanisms
for funding new fields, collaborative research,
and alternatives to animal research were also
suggested (13, 16, 17). Each report makes
important points in support of these proposed
mechanisms, but the lack of consensus in-
dicates a requirement for further discussion.
Conclusion
Multiple groups have identified problems and
made recommendations that would improve
the research enterprise while strengthening
independent, investigator-initiated research,
broadening the rigorous training of young
scientists, and maintaining innovation. Many
of these recommendations have been dis-
cussed for years, and we propose that the
scientific community begins implementation
of the eight recommendations on which there
is broad consensus.
The eight consensus recommendations
identified here are complementary, and there
are advantages to simultaneous implementa-
tion. For example, long-term budget planning
can provide the transparency needed to sta-
bilize and increase research funding. Similarly,
concomitantly increasing postdoc pay, re-
stricting training periods, and broadening
training experiences will tend to reduce grad-
uate student and postdoc populations and
may allow the NIH to passively increase the
percentage of trainees funded by training
grants and fellowships.
Although concomitant implementation of
the consensus recommendations is advisable,
it must still be done with care. Any in-
creases in costs associated with implementa-
tion should ideally be covered by increased
congressional appropriations and should not
be taken from research project grants, which
are already significantly strained. Care should
also be taken to ensure that actions such as
shifting trainee support toward training grants
and fellowships do not unduly harm programs
at smaller or less prestigious institutions that
cannot compete effectively for these grants. All
of the consensus recommendations will have
effects on the research enterprise and should
therefore be monitored closely, with federal
agencies and the scientific community jointly
defining the metrics for success.
Young scientists bring vital, fresh ideas and
perspectives to the research enterprise, and
improving graduate student and postdoc
training will strengthen the research enter-
prise. However, the reports do not agree on
whether academia is producing too many
PhDs, and there is a relative lack of data
assessing supply and demand of PhDs and
market capacity. Nevertheless, implementing
consensus recommendations 4 through 8 will
likely reduce the number of trainees and shift
the research enterprise toward a more bal-
anced mix of trainees and staff scientists.
In summary, stakeholders are rightly con-
cerned that taking specific actions may dam-
age the enterprise. However, a “do no harm”
approach ignores the fact that doing nothing
has exacerbated the current situation and will
be even more harmful in the future. Our
community must therefore now act to rein-
vigorate the US scientific enterprise and en-
sure that we remain a global leader in research.
ACKNOWLEDGMENTS. We thank Erica Siebrasse,
Matthew Gentry, Gerald Carlson, Lee Gehrke, Angela
Hopp, Kenneth Gibbs, Jessica Polka, Gary McDowell,
Kristin Krukenberg, Melissa Vaught, and Don Ayer
for insightful comments.
1 American Association for the Advancement of Science (2015)
Trends in R&D by Agency (American Association for the
Advancement of Science, Washington, DC). Available at www.aaas.
org/sites/default/files/Agencies_0.jpg. Accessed January 30, 2015.
2 National Institutes of Health Data Book (2014) Research Grants –
Research Project Grants: Success rates of new (type 1) competing
applications for targeted and untargeted research (National Institutes
of Health, Bethesda, MD). Available at report.nih.gov/nihdatabook/.
Accessed January 30, 2015.
3 Berg J (2014) The impact of the sequester: 1000 fewer funded
investigators. ASBMB Today 13(3):2–4.
4 Daniels RJ (2015) A generation at risk: Young investigators and the
future of the biomedical workforce. Proc Natl Acad Sci USA 112(2):
313–318.
5 Malakoff D (2014) After Election 2014: Easing Research
Regulation (American Association for the Advancement of Science,
Washington, DC), Available at news.sciencemag.org/education/
2014/11/after-election-2014-easing-research-regulation. Accessed
January 30, 2015.
6 Lei Z, Juneja R, Wright BD (2009) Patents versus patenting:
Implications of intellectual property protection for biological research.
Nat Biotechnol 27(1):36–40.
7 American Society for Biochemistry and Molecular Biology (2013)
Unlimited Potential, Vanishing Opportunity (American Society for
Biochemistry and Molecular Biology, Rockville, MD).
8 American Society for Biochemistry and Molecular Biology (2013)
Toward a Sustainable Biomedical Research Enterprise (American
Society for Biochemistry and Molecular Biology, Rockville, MD).
9 Alberts B, Kirschner MW, Tilghman S, Varmus H (2014) Rescuing
US biomedical research from its systemic flaws. Proc Natl Acad Sci
USA 111(16):5773–5777.
10 American Academy of Arts and Sciences (2014) Restoring the
Foundation: The Vital Role of Research in Preserving the American
Dream (American Academy of Arts and Sciences, Cambridge, MA).
11 Federation of American Societies for Experimental Biology (2015)
Sustaining Discovery in Biological and Medical Sciences (Federation
of American Societies for Experimental Biology, Bethesda, MD).
12 McDowell GS, et al. (2014) Shaping the future of research: A
perspective from junior scientists. F1000Res 3:291, Version 2 (revised
January 9, 2015). Available at f1000research.com/articles/3-291/v2.
13 National Research Council (2012) Research Universities and the
Future of America: Ten Breakthrough Actions Vital to Our Nation’s
Prosperity and Security (National Academies Press, Washington, DC).
14 National Academy of Science, National Academy of Engineering,
and Institute of Medicine (2014) The Postdoctoral Experience
Revisited (National Academies Press, Washington, DC).
15 National Institutes of Health (2012) Biomedical Research Workforce
Working Group Report (National Institutes of Health, Bethesda, MD).
16 National Science Board (2014) Reducing Investigators’
Administrative Workload for Federally Funded Research (National
Science Board, Washington, DC).
17 President’s Council of Advisors on Science and Technology
(2012) Transformation and Opportunity: The Future of the U.S.
Research Enterprise (President’s Council of Advisors on Science and
Technology, Washington, DC).
18 Battelle (2013) 2014 Global R&D Funding Forecast (Battelle,
Columbus, OH).
19 Akabas S, Collins B (2014) What is the Research and
Experimentation Tax Credit? (Bipartisan Policy Center, Washington,
DC), Available at bipartisanpolicy.org/blog/what-research-and-
experimentation-tax-credit/. Accessed March 2, 2015.
20 Comstock B (2015) H.R. 1119 Research and Development
Efficiency Act (U.S. Government Publishing Office, Washington, DC).
21 National Center for Science and Engineering Statistics (2014)
Science and Engineering Doctorates Annual Digest Report and Data
Tables: Doctorate Recipients from U.S. Universities, 2013 (National
Science Foundation, Arlington, VA).
22 National Center for Science and Engineering Statistics (2013) Survey
of Doctorate Recipients (National Science Foundation, Arlington, VA).
23 Rockey S (2013) Diversifying the Training Experiences of the
Biomedical Research Workforce (National Institutes of Health,
Bethesda, MD), Available at https://nexus.od.nih.gov/all/2013/03/08/
diversifying-the-training-experiences-of-the-biomedical-research-
workforce/. Accessed March 2, 2015.
24 Hask L (2002) A Career-Development Plan for Postdocs
(American Association for the Advancement of Science, Washington,
DC), Available at sciencecareers.sciencemag.org/career_magazine/
previous_issues/articles/2002_10_18/nodoi.15973082408969265315.
Accessed April 17, 2015.
25 National Institutes of Health (2014) Revised Policy: Descriptions
on the Use of Individual Development Plans (IDPs) for Graduate
Students and Postdoctoral Researchers Required in Annual Progress
Reports beginning October 1, 2014 (National Institutes of Health,
Bethesda MD), Notice no. NOT-OD-14-113. Available at grants.nih.gov/
grants/guide/notice-files/NOT-OD-14-113.html. Accessed April 17, 2015.
26 National Institutes of Health Data Book (2014) National Statistics
on Postdoctorates in the Biomedical, Behavioral, Social, and Clinical
Sciences: Primary Source of Support for Postdoctorates in the
Biomedical Sciences (National Institutes of Health, Bethesda MD).
Available at report.nih.gov/nihdatabook/. Accessed March 2, 2015.
27 National Institutes of Health Data Book (2014) National Statistics
on Graduate Students in the Biomedical, Behavioral, Social, and
Clinical Sciences: Primary Mechanisms of National Institutes of
Health (NIH) Support for Full-Time Graduate Students in the
Biomedical Sciences (National Institutes of Health, Bethesda, MD).
Available at report.nih.gov/nihdatabook/. Accessed March 2, 2015.
28 Kaiser J (2015) Cancer Institute Plans New Award for Staff Scientists
(American Association for the Advancement of Science, Washington, DC),
Available at news.sciencemag.org/biology/2015/03/cancer-institute-plans-
new-award-staff-scientists. Accessed March 20, 2015.
29 National Institutes of Health (2012) Draft Report of the Advisory
Committee to the Director Working Group on Diversity in the
Biomedical Research Workforce (National Institutes of Health,
Bethesda, MD).
30 Hong L, Page SE (2004) Groups of diverse problem solvers can
outperform groups of high-ability problem solvers. Proc Natl Acad Sci
USA 101(46):16385–16389.
31 National Institutes of Health (2015) Enhancing the Diversity of
the NIH-Funded Workforce (National Institutes of Health, Bethesda,
MD). Available at https://commonfund.nih.gov/diversity/index.
Accessed March 20, 2015.
32 National Academy of Science, National Academy of Engineering,
and Institute of Medicine (2011) Expanding Underrepresented
Minority Participation: America’s Science and Technology Talent at
the Crossroads (National Academies Press, Washington DC).
33 Ginther DK, et al. (2011) Race, ethnicity, and NIH research
awards. Science 333(6045):1015–1019.
34 Day TE (2015) The big consequences of small biases: A
simulation of peer review. Res Policy 44(6):1266–1270.
Pickett et al. PNAS | September 1, 2015 | vol. 112 | no. 35 | 10835
PE
RS
PE
CT
IV
E
35 Gibbs KD, Jr, McGready J, Bennett JC, Griffin K (2014) Biomedical
Science Ph.D. Career Interest Patterns by Race/Ethnicity and Gender.
PLoS One 9(12):e114736.
36 Williams JC, Phillips KW, Hall EV (2015) Double Jeopardy?
Gender Bias Against Women of Color in Science (UC Hastings
College of Law, San Francisco, CA).
37 Levine AS, et al. (2015) Research in academic medical
centers: Two threats to sustainable support. Sci Transl Med
7(289):289fs22.
38 National Research Council (2010) Managing University
Intellectual Property in the Public Interest (National Academies Press,
Washington, DC).
39 American Academy of Arts and Sciences (2013) Advancing
Research in Science and Engineering 2: Unleashing America’s
Research & Innovation Enterprise (American Academy of Arts and
Sciences, Cambridge, MA).
40 Collins FS, Tabak LA (2014) Policy: NIH plans to
enhance reproducibility. Nature 505(7485):612–613.
10836 | www.pnas.org/cgi/doi/10.1073/pnas.1509901112 Pickett et al.
